Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Sales ratio is N/A as of 2026-10-06T13:36:30.108Z.
Calculation as of: 2026-10-06T13:36:30.108Z.
Quote observation: 2026-10-06T13:33:48.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 36850a73a8dd64042e14cdb756c8aff586d88f9314e30134a37dd84cc424cdb4
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-03-13.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
N/A
EV/SALES RATIO AVG TTM
167.52x
EV/SALES RATIO AVG 3Y
N/A
EV/SALES RATIO AVG 5Y
N/A
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Ernexa Therapeutics Inc.
Market Cap
$4.49M
EV/Sales Ratio
N/A
TTM Avg
167.52x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.54M
EV/Sales Ratio
13.36x
TTM Avg
5.50x
3Y Avg
15.32x
5Y Avg
34.36x
Market Cap
$4.36M
EV/Sales Ratio
N/A
TTM Avg
66867.68x
3Y Avg
66867.68x
5Y Avg
66867.68x
Market Cap
$4.63M
EV/Sales Ratio
6.39x
TTM Avg
29.50x
3Y Avg
46.21x
5Y Avg
38.89x
Market Cap
$4.80M
EV/Sales Ratio
0.54x
TTM Avg
5.83x
3Y Avg
31.22x
5Y Avg
31.22x
Market Cap
$4.84M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | $4.49M | N/A | 167.52x | N/A | N/A |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.50M | N/A | N/A | N/A | N/A |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.54M | 13.36x | 5.50x | 15.32x | 34.36x |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.42M | 0.22x | 0.77x | 0.77x | 0.77x |
| GRI Bio, Inc. (GRI)vs › | $4.36M | N/A | 66867.68x | 66867.68x | 66867.68x |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.63M | 6.39x | 29.50x | 46.21x | 38.89x |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.80M | 0.54x | 5.83x | 31.22x | 31.22x |
| CalciMedica, Inc. (CALC)vs › | $4.82M | N/A | N/A | N/A | N/A |
| Gelteq Limited Ordinary Shares (GELS)vs › | $4.84M | N/A | N/A | N/A | N/A |
| Aptevo Therapeutics Inc. (APVO)vs › | $4.13M | N/A | 0.35x | 5.55x | 4.43x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-03-13 | 170.22x |
| 2026-03-12 | 48.48x |
| 2026-03-05 | 32.03x |
| 2026-03-04 | 25.45x |
| 2026-02-20 | 15.58x |
| 2026-02-19 | 538.75x |
| 2026-02-18 | 440.04x |
| 2026-02-17 | 219.58x |
| 2026-02-13 | 163.64x |
| 2026-02-12 | 499.26x |
| 2026-02-10 | 15.58x |
| 2026-02-09 | 45.19x |
| 2026-02-06 | 601.27x |
| 2026-02-05 | 3098.68x |
| 2026-02-04 | 4477.36x |
| 2026-02-03 | 5072.92x |
| 2026-02-02 | 7705.24x |
| 2026-01-30 | 7540.72x |
| 2026-01-29 | 7376.20x |
| 2026-01-28 | 7705.24x |
| 2026-01-27 | 7047.16x |
| 2026-01-26 | 7129.42x |
| 2026-01-23 | 7376.20x |
| 2026-01-22 | 7705.24x |
| 2026-01-21 | 7211.68x |
| 2026-01-20 | 7540.72x |
| 2026-01-16 | 7458.46x |
| 2026-01-15 | 7211.68x |
| 2026-01-14 | 7952.02x |
| 2026-01-13 | 7705.24x |
| 2026-01-12 | 8198.80x |
| 2026-01-09 | 8281.06x |
| 2026-01-08 | 8939.14x |
| 2026-01-07 | 7705.24x |
| 2026-01-06 | 7952.02x |
| 2026-01-05 | 7458.46x |
| 2026-01-02 | 7047.16x |
| 2025-12-31 | 7376.20x |
| 2025-12-30 | 7129.42x |
| 2025-12-29 | 7129.42x |
| 2025-12-26 | 7458.46x |
| 2025-12-24 | 7952.02x |
| 2025-12-23 | 7705.24x |
| 2025-12-22 | 8034.28x |
| 2025-12-19 | 8281.06x |
| 2025-12-18 | 7869.76x |
| 2025-12-17 | 7705.24x |
| 2025-12-16 | 8281.06x |
| 2025-12-15 | 8116.54x |
| 2025-12-12 | 8692.36x |
| 2025-12-11 | 9679.48x |
| 2025-12-10 | 8034.28x |
| 2025-12-09 | 8692.36x |
| 2025-12-08 | 8198.80x |
| 2025-12-05 | 8363.32x |
| 2025-12-04 | 8281.06x |
| 2025-12-03 | 6964.90x |
| 2025-12-02 | 7376.20x |
| 2025-12-01 | 7787.50x |
| 2025-11-28 | 8610.10x |
| 2025-11-26 | 8856.88x |
| 2025-11-25 | 8610.10x |
| 2025-11-24 | 8116.54x |
| 2025-11-21 | 8610.10x |
| 2025-11-20 | 8034.28x |
| 2025-11-19 | 8939.14x |
| 2025-11-18 | 9679.48x |
| 2025-11-17 | 9926.26x |
| 2025-11-14 | 10008.52x |
| 2025-11-13 | 10419.82x |
| 2025-11-12 | 10748.86x |
| 2025-11-11 | 10502.08x |
| 2025-11-10 | 11242.42x |
| 2025-11-07 | 10.95x |
| 2025-11-06 | 10.31x |
| 2025-11-05 | 9.88x |
| 2025-11-04 | 10.20x |
| 2025-11-03 | 10.10x |
| 2025-10-31 | 12.32x |
| 2025-10-30 | 11.26x |
| 2025-10-29 | 11.05x |
| 2025-10-28 | 5.64x |
| 2025-10-27 | 5.00x |
| 2025-10-24 | 5.53x |
| 2025-10-23 | 4.79x |
| 2025-10-22 | 4.58x |
| 2025-10-21 | 5.21x |
| 2025-10-20 | 5.64x |
| 2025-10-17 | 5.32x |
| 2025-10-16 | 5.64x |
| 2025-10-15 | 6.38x |
| 2025-10-14 | 6.06x |
| 2025-10-13 | 5.64x |
| 2025-10-10 | 6.17x |
| 2025-10-09 | 6.59x |
| 2025-10-08 | 6.91x |
| 2025-10-07 | 6.28x |
| 2025-10-06 | 6.81x |
| 2025-10-03 | 5.11x |
| 2025-10-02 | 5.32x |
| 2025-10-01 | 4.47x |
| 2025-09-30 | 4.05x |
| 2025-09-29 | 4.79x |
| 2025-09-26 | 4.47x |
| 2025-09-25 | 4.26x |
| 2025-09-24 | 4.37x |
| 2025-09-23 | 5.21x |
| 2025-09-22 | 5.21x |
| 2025-09-19 | 6.49x |
| 2025-09-18 | 5.85x |
| 2025-09-17 | 4.90x |
| 2025-09-16 | 5.64x |
| 2025-09-15 | 4.90x |
| 2025-09-12 | 6.06x |
| 2025-09-11 | 7.02x |
| 2025-09-10 | 6.06x |
| 2025-09-09 | 5.74x |
| 2025-09-08 | 5.53x |
| 2025-09-05 | 5.64x |
| 2025-09-04 | 5.32x |
| 2025-09-03 | 6.91x |
| 2025-09-02 | 6.59x |
| 2025-08-29 | 6.49x |
| 2025-08-28 | 7.02x |
| 2025-08-27 | 7.12x |
| 2025-08-26 | 8.19x |
| 2025-08-25 | 7.55x |
| 2025-08-22 | 8.29x |
| 2025-08-21 | 8.50x |
| 2025-08-20 | 8.82x |
| 2025-08-19 | 8.82x |
| 2025-08-18 | 9.46x |
| 2025-08-15 | 9.25x |
| 2025-08-14 | 9.57x |
| 2025-08-13 | 164.38x |
| 2025-08-12 | 170.36x |
| 2025-08-11 | 163.38x |
| 2025-08-08 | 171.36x |
| 2025-08-07 | 166.37x |
| 2025-08-06 | 169.37x |
| 2025-08-05 | 170.36x |
| 2025-08-04 | 157.40x |
| 2025-08-01 | 157.40x |
| 2025-07-31 | 174.35x |
| 2025-07-30 | 186.32x |
| 2025-07-29 | 180.34x |
| 2025-07-28 | 192.31x |
| 2025-07-25 | 196.30x |
| 2025-07-24 | 211.26x |
| 2025-07-23 | 222.23x |
| 2025-07-22 | 202.28x |
| 2025-07-21 | 197.29x |
| 2025-07-18 | 199.29x |
| 2025-07-17 | 205.27x |
| 2025-07-16 | 198.29x |
| 2025-07-15 | 193.30x |
| 2025-07-14 | 197.29x |
| 2025-07-11 | 196.30x |
| 2025-07-10 | 199.29x |
| 2025-07-09 | 196.30x |
| 2025-07-08 | 193.30x |
| 2025-07-07 | 184.33x |
| 2025-07-03 | 201.28x |
| 2025-07-02 | 199.29x |
| 2025-07-01 | 183.33x |
| 2025-06-30 | 185.32x |
| 2025-06-27 | 186.32x |
| 2025-06-26 | 191.31x |
| 2025-06-25 | 189.31x |
| 2025-06-24 | 199.29x |
| 2025-06-23 | 241.18x |
| 2025-06-20 | 246.17x |
| 2025-06-18 | 264.12x |
| 2025-06-17 | 254.14x |
| 2025-06-16 | 240.18x |
| 2025-06-13 | 230.21x |
| 2025-06-12 | 238.19x |
| 2025-06-11 | 239.18x |
| 2025-06-10 | 234.20x |
| 2025-06-09 | 285.06x |
| 2025-06-06 | 271.10x |
| 2025-06-05 | 274.09x |
| 2025-06-04 | 271.10x |
| 2025-06-03 | 271.10x |
| 2025-06-02 | 329.95x |
| 2025-05-30 | 327.95x |
| 2025-05-29 | 344.91x |
| 2025-05-28 | 345.91x |
| 2025-05-27 | 359.87x |
| 2025-05-23 | 342.91x |
| 2025-05-22 | 343.91x |
| 2025-05-21 | 345.91x |
| 2025-05-20 | 359.87x |
| 2025-05-19 | 345.91x |
| 2025-05-16 | 336.93x |
| 2025-05-15 | 351.89x |
| 2025-05-14 | 372.84x |
| 2025-05-13 | 329.95x |
| 2025-05-12 | 315.98x |
| 2025-05-09 | 300.03x |
| 2025-05-08 | 301.02x |
| 2025-05-07 | 272.79x |
| 2025-05-06 | 273.68x |
| 2025-05-05 | 260.43x |
| 2025-05-02 | 266.61x |
| 2025-05-01 | 257.78x |
| 2025-04-30 | 272.79x |
| 2025-04-29 | 273.68x |
| 2025-04-28 | 278.09x |
| 2025-04-25 | 284.27x |
| 2025-04-24 | 269.26x |
| 2025-04-23 | 255.13x |
| 2025-04-22 | 241.89x |
| 2025-04-21 | 234.83x |
| 2025-04-17 | 243.66x |
| 2025-04-16 | 241.89x |
| 2025-04-15 | 263.08x |
| 2025-04-14 | 274.56x |
| 2025-04-11 | 251.60x |
| 2025-04-10 | 244.54x |
| 2025-04-09 | 261.31x |
| 2025-04-08 | 225.12x |
| 2025-04-07 | 245.42x |
| 2025-04-04 | 248.95x |
| 2025-04-03 | 238.36x |
| 2025-04-02 | 251.60x |
| 2025-04-01 | 242.77x |
| 2025-03-31 | 233.94x |
| 2025-03-28 | 229.53x |
| 2025-03-27 | 297.51x |
| 2025-03-26 | 302.81x |
| 2025-03-25 | 323.12x |
| 2025-03-24 | 342.54x |
| 2025-03-21 | 348.72x |
| 2025-03-20 | 356.67x |
| 2025-03-19 | 364.62x |
| 2025-03-18 | 349.61x |
| 2025-03-17 | 361.08x |
| 2025-03-14 | 338.13x |
| 2025-03-13 | 336.36x |
| 2025-03-12 | 84.25x |
| 2025-03-11 | 85.34x |
| 2025-03-10 | 85.70x |
| 2025-03-07 | 87.69x |
| 2025-03-06 | 88.96x |
| 2025-03-05 | 87.60x |
| 2025-03-04 | 87.78x |
| 2025-03-03 | 86.88x |
| 2025-02-28 | 90.22x |
| 2025-02-27 | 87.78x |
| 2025-02-26 | 89.05x |
| 2025-02-25 | 88.78x |
| 2025-02-24 | 89.86x |
| 2025-02-21 | 91.67x |
| 2025-02-20 | 94.93x |
| 2025-02-19 | 96.65x |
| 2025-02-18 | 90.13x |
| 2025-02-14 | 90.68x |
| 2025-02-13 | 88.05x |
| 2025-02-12 | 84.52x |
Showing the most recent 260 of 570 data points. The chart above shows the full history.
